A brief review of complex regional pain syndrome and current management.
Annals of medicine – December 01, 2024
Source: PubMed
Summary
Chronic pain that spreads beyond an initial injury affects 200,000 Americans yearly. Treatment options have expanded dramatically, combining traditional medications like gabapentin and ketamine with innovative therapies. Doctors now use precise diagnostic tools (Budapest criteria) to identify this condition early. Advanced treatments include spinal cord stimulation, nerve blocks, and botulinum toxin injections. While severe cases may require amputation, most patients improve with early intervention and antioxidant therapy.
Abstract
Complex regional pain syndrome (CRPS) is a debilitating chronic pain condition that, although exceedingly rare, carries a significant burden for the affected patient population. The complex and ambiguous pathophysiology of this condition further complicates clinical management and therapeutic interventions. Furthermore, being a diagnosis of exclusion requires a diligent workup to ensure an accurate diagnosis and subsequent targeted management. The development of the Budapest diagnostic criteria helped to consolidate existing definitions of CRPS but extensive work remains in identifying the underlying pathways. Currently, two distinct types are identified by the presence (CRPS type 1) or absence (CRPS type 2) of neuronal injury. Current management directed at this disease is broad and growing, ranging from non-invasive modalities such as physical and psychological therapy to more invasive techniques such as dorsal root ganglion stimulation and potentially amputation. Ideal therapeutic interventions are multimodal in nature to address the likely multifactorial pathological development of CRPS. Regardless, a significant need remains for continued studies to elucidate the pathways involved in developing CRPS as well as more robust clinical trials for various treatment modalities.